Efficacy of sorafenib correlates with Memorial Sloan-Kettering Cancer Center (MSKCC) risk classification and bone metastasis in Chinese patients with metastatic renal cell carcinoma.

Autor:	Zhang, Yushi1, Li, Yongqiang1, Cai, Yi1, Li, Hanzhong1, Wang, Ke2
Zdroj:	Cellular Oncology (2211-3428). Feb2016, Vol. 39 Issue 1, p15-21. 7p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu